Articles On Nanollose (ASX:NC6)
Title | Source | Codes | Date |
---|---|---|---|
Check Up: Big breakthrough in acne treatment, and recent ASX biotech winners
There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month Scientists have made a significant b... |
Stockhead | NC6 | 12 hours ago |
ASX Health Winners February: Law of attrition applies but biotech is a long term game; Nyrada up 5x last month
ASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essentially, biotech is a long term game for investors The S&P/ASX 200 Health Care [XHJ] struggled in February, finishing -1.5% lower and tr... |
Stockhead | NC6 | 1 month ago |
Check Up: Big week in world of biotech after these 2 Nasdaq stocks announce breakthroughs
Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks There were a couple of big news from the world of biotec... |
Stockhead | NC6 | 1 month ago |
Closing Bell: Local markets ride commodities higher after a blow to US confidence on Friday
Local markets ride commodities lift to offset weak performance from Wall Street on Friday ASX 200 benchmark finished the day on +0.09pc, a lot higher than it really had any right to Resources led the way, overcoming a significant deadwei... |
Stockhead | NC6 | 2 months ago |
Closing Bell: Blood plasma giant CSL bleeds out in front of entire ASX on Monday
ASX200 dragged down by bad drugs The IT Sector is up 1.1pc, Healthcare is down about 3.2pc Small cap winners led by American Rare Earths and Appen The benchmark was shot through the heart by CSL this morning leaving everything else in... |
Stockhead | NC6 | 2 months ago |
Top 10 at 11: Boardroom battles and spinning drills are driving the market this morning
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by... |
Stockhead | NC6 | 5 months ago |
Check Up: Biden-Xi meeting could finally end opioids crisis in the US; and recent ASX biotech winners
Xi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks China’s President Xi is expected... |
Stockhead | NC6 | 5 months ago |
Closing Bell: Friday takes a bite out of ASX, even as biotech and lithium small caps run amok
The ASX has ended the week lower, down 0.55pc on Friday Healthcare Sector remains defiant Small caps led by medtech names and Lake Johnston lithium hunters The fickle Aussie sharemarket has given back on Friday all that it has made thi... |
Stockhead | NC6 | 5 months ago |
Closing Bell: ASX in disgrace after crashing to 12-month low
Benchmark ASX index ends -0.6 lower Utilities only sector in the green Small caps led by LSA, AZS The ASX200 has closed 42 points (-0.61%) lower on Thursday. May as well get you a pic. I’ll point out the important bits… ASX200 ON THUR... |
Stockhead | NC6 | 5 months ago |
Closing Bell: ASX ends flat, but it’s not a good flat. More an Oxford Dictionary ‘to lack vigour; dull and lifeless’ flat
Benchmark ASX index closes short by -0.04% Materials sector tries but cannot offset everyone else Small caps led by HAL, DTC The ASX200 Index has closed slightly lower after jumping early (+0.3%) out the gates on Wednesday morning. The... |
Stockhead | NC6 | 5 months ago |
Closing Bell: ASX unconvincing ahead of big CPI read and maiden address by new RBA boss
Benchmark ASX index closes ahead +0.19% Materials lead ASX sectors on Tuesday Small caps led by ERW, NMR Local markets have struggled to hang onto early gains after a mixed run on Wall Street overnight. The benchmark ASX200 (XJO) index... |
Stockhead | NC6 | 6 months ago |
Check Up: Why Goldman Sachs won’t change its ratings on 3 ASX stocks despite Ozempic-driven selloff
News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks Goldman Sachs analysts said they will make no... |
Stockhead | NC6 | 6 months ago |
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it
L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks Be... |
Stockhead | NC6 | 6 months ago |
Check Up: What is the FDA emergency use authorisation, and which ASX stocks were given approval?
The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks On... |
Stockhead | NC6 | 7 months ago |
ASX Biotech August Winners: Sector down despite CSL and Cochlear’s strong results, but don’t panic…
Earnings reports dominated headlines in August Despite solid results from ASX healthcare giants, the sector finished lower We take a look at which ASX healthcare stocks performed the best in August August was all about earnings, and des... |
Stockhead | NC6 | 7 months ago |
Check Up: Australian biotech sector continues to be a magnet for US investors
Australian biotech has attracted US investments in the last five years Among ASX stocks to get funded from the US include Opthea We look at the best and worst performing ASX biotechs over the past month The Australian biotech sector co... |
Stockhead | NC6 | 7 months ago |
Top 10 at 10-ish: Great White win for Andromeda, but things aren’t so great for EMS
Stockhead’s Top 10 at 11, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | NC6 | 8 months ago |
Closing Bell: ASX rises despite tech meltdown; Domino’s fires everyone, stock jumps
ASX 200 benchmark climbs 0.5% Tech Sector plunges 5.5% while Consumer stocks and iron ore majors save day Small cap gains led by huge day at 4DS The Australian share market extracted some green from a dull Wednesday wicket after the Wa... |
Stockhead | NC6 | 8 months ago |
Check Up: Biotech is worth ‘US$4 trillion in 10 years’, and here’s where the smart money will go
Biotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two growing themes in the space We look at the best and worst performing ASX biotechs over the past month Steve Jobs used to say that the most... |
Stockhead | NC6 | 8 months ago |
ASX Biotech Winners in July: Down but far from out, here’s why biotechs could stage a comeback
The end of pandemic and higher rates have subdued biotech market But there are signs now the sector is making a comeback We take a look at the ASX Biotech Winners in July The Covid-19 pandemic had produced windfalls for and attracted fa... |
Stockhead | NC6 | 8 months ago |
In Case You Missed It: Data centres, gold and cannabis take the lead
Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms... |
Stockhead | NC6 | 8 months ago |
CLOSING BELL: ASX rises 1.5pc today, with the Goldies out in front on 3.54pc
ASX snaps a 4-day run of bruising luck with a welcome 1.5% gain Techies did a lot of the heavy lifting, while the Goldies put on a +3.54% show The day’s clear winner was Mobilicom, up 150% at day’s end on juicy defence news Local market... |
Stockhead | NC6 | 9 months ago |
CLOSING BELL: ASX falters with no US market to copy today
S&P/ASX 200 closes in the red today: -0.35%, as US stock markets enjoy a July 4 chilli dog, or something Sectors-wise, Telcos are ringing in the gainz… annnd that’s about it. Okay, Utilities are going alright Standout stocks: Krakatoa... |
Stockhead | NC6 | 9 months ago |
In Case You Missed It: Lithium, nickel and a Peruvian divestment deal
Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms... |
Stockhead | NC6 | 9 months ago |
In Case You Missed It: Rare earths, lithium and a dash of nickel
Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms... |
Stockhead | NC6 | 9 months ago |
Check Up: Brisbane based Vaxxas set to disrupt market with game-changing, needle-free vaccines
Brisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “game changer” We look at the best and worst performing ASX biotechs over the past month The world is anticipating a “game changer” as Brisba... |
Stockhead | NC6 | 10 months ago |
In Case You Missed It: Gold, rare earths and a digital healthcare deal
Stockhead’s In-Case-You-Missed-It highlights some strongest-performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms... |
Stockhead | NC6 | 10 months ago |
In Case You Missed It: Lithium, iron ore, and iron ore switching to lithium
Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms... |
Stockhead | NC6 | 10 months ago |
Less swings, more roundabouts for these ASX companies driving the circular economy
Several ASX companies are driving Australia’s circular economy, prioritising resource conservation and sustainability Nanollose is working to produce tree-free cellulose, instead using an eco-friendly fermentation process to grow fibres... |
Stockhead | NC6 | 10 months ago |
In Case You Missed It: Nickel hits, Canadian lithium and some more nickel
Stockhead’s In-Case-You-Missed-It highlights some strongest-performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms... |
Stockhead | NC6 | 10 months ago |
In Case You Missed It: Tech takeover takes the cake
Stockhead’s In-Case-You-Missed-It highlights some of the strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentag... |
Stockhead | NC6 | 10 months ago |
In Case You Missed It: Spectacular gold, an authentication deal and some lithium
Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms... |
Stockhead | NC6 | 10 months ago |
Check Up: Here’s the handful of ASX small cap health stocks that actually pay dividends
Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week When we talk about dividend-paying hea... |
Stockhead | NC6 | 10 months ago |
ASX Biotech Winners in May: We’re finally seeing signs of life on the back of another clinical breakthrough
Biotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We take a look at the ASX biotech winners in May There are clear signs the biotech sector is springing back to life after a disappointing 2... |
Stockhead | NC6 | 10 months ago |
In Case You Missed It: Lithium takes the lead, followed by biotech and manganese today
Stockhead’s In-Case-You-Missed-It highlights some of the strongest-performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentag... |
Stockhead | NC6 | 11 months ago |
CLOSING BELL: Can you guess which company we all gave $2.7bn to announced a record $2.5bn profit today?
The ASX closed out the day flat, thanks to a last-minute selling spree Qantas announces record profit but still won’t give us back the money we gave them during Covid Westar Resources won the Small Caps race, in spite of a 90-minute hobbli... |
Stockhead | NC6 | 11 months ago |
ASX Health Stocks: 4DMedical makes breakthrough, potentially disrupts century-old method
4DMedical announced a significant breakthrough in imaging technology Bod Australia announced updates on its Aqua Phase Delivery technology Nanollose to strengthen balance sheet after receiving R&D tax rebate 4DMedical says its CT t... |
Stockhead | NC6 | 11 months ago |
In Case You Missed It: Zinc, gold and lithium take the cake today
Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms... |
Stockhead | NC6 | 11 months ago |
In Case You Missed It: High-grade lithium results and a massive 1.3Moz gold resource
Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms.... |
Stockhead | NC6 | 11 months ago |
Nanollose files patent for breakthrough in microbial cellulose technology
Biomaterial tech company Nanollose is adding to its growing portfolio of intellectual property, filing a new provisional patent application with IP Australia, this time for its alternative seed germination and plant growing material Jelli G... |
Stockhead | NC6 | 11 months ago |
In Case You Missed it: Medicinal cannabis acquisitions and double digit gold grades
Stockhead’s In Case You Missed It highlights some of the strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage... |
Stockhead | NC6 | 11 months ago |
In Case You Missed It: Rare earth riches are enjoying their time in the sun
Stockhead’s In Case You Missed It highlights some of the strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage... |
Stockhead | NC6 | 11 months ago |
In Case You Missed It: Rare earth discoveries sends one small cap spinning and a $3m engine contract deal
Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms.... |
Stockhead | NC6 | 11 months ago |
In Case You Missed It: Lithium, Rare earths, and nickel news to feast your eyes on
Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms.... |
Stockhead | NC6 | 11 months ago |
In Case You Missed It: Niobium hits and a big battery metals offtake deal
Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms... |
Stockhead | NC6 | 11 months ago |
Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m quarterly sales
Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s... |
Stockhead | NC6 | 11 months ago |
In Case You Missed It: Lithium, edtech in India and base metals players hit the gas
Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms... |
Stockhead | NC6 | 1 year ago |
Nanollose completes second pilot spin of ground-breaking, tree-friendly, Nullarbor lyocell fibre
Nanollose has completed its second pilot spin of its sustainable Nullarbor lyocell fibre, successfully increasing the microbial cellulose content. Australia-based biomaterial technology company Nanollose (ASX:NC6) has completed a milestone... |
Stockhead | NC6 | 1 year ago |
CLOSING BELL: Brace yourselves… even the clowns in charge don’t know what’s coming.
Benchmark set to finish close to flat as Energy stocks slump again Goldies are surging again, with that sector up 1.3% for the day Even the big banks are bracing for trouble with talk of a crisis getting louder by the day After a modera... |
Stockhead | NC6 | 1 year ago |
Nanollose extends deal with partner Grasim Industries as works to commercialise tree-free fibre
Nanollose has extended its deal with fibre manufacturing conglomerate Grasim Industries as it works to get its forest-friendly Nullarbor fibres to market. Australia-based biomaterial technology company Nanollose (ASX:NC6) has announced it... |
Stockhead | NC6 | 1 year ago |